(Reuters) – Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that[...]
Read more
Health
E-cigarette maker Juul reaches settlement with nearly 10,000 plaintiffs
(Reuters) -E-cigarette maker Juul Labs on Tuesday said it has reached settlements with about 10,000 plaintiffs covering more than 5,000 cases in California. Juul did not disclose the settlement amount[...]
Read more
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
By Brendan Pierson (Reuters) – Drugmakers GSK Plc, Pfizer Inc, Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused[...]
Read more
U.S. FDA grants priority review for Emergent’s OTC opioid drug
(Reuters) -Contract drugmaker Emergent Biosolutions said on Tuesday its over-the-counter nasal spray as a treatment for suspected opioid overdose would be reviewed on a priority basis by the U.S. heal[...]
Read more
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
By Blake Brittain (Reuters) -Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsui[...]
Read more
Exclusive: Musk’s Neuralink faces federal probe, employee backlash over animal tests
By Rachael Levy (Reuters) – Elon Musk’s Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations amid internal staff complaints that its animal[...]
Read more
Foxconn sees COVID-hit China plant back at full output in late Dec-early Jan -source
By Yimou Lee TAIPEI (Reuters) – Apple supplier Foxconn expects its COVID-hit Zhengzhou plant in China to resume full production around late December to early January, a Foxconn source said on Mo[...]
Read more
Investors bet China’s rally on easing COVID curbs will be furious but fleeting
By Jason Xue and Summer Zhen SHANGHAI/HONG KONG (Reuters) – Investors piling into China’s tourism, catering and beverage stocks as Beijing eases strict COVID-19 curbs are also keeping an e[...]
Read more
No plans to go back to Congress to change inflation act – White House
WASHINGTON (Reuters) – There are no plans to go back to Congress to push for changes to the Inflation Reduction Act, the White House said Friday, a day after President Joe Biden said it could be[...]
Read more